Finch Therapeutics Group, Inc. FNCHQ
10.35
0.00
0.00%
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow FNCHQ
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '23 | Dec '23 | Mar '24 | Jun '24 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
5.90 | 6.15 | 5.93 | 3.59 | |
Current Ratio |
6.13 | 6.33 | 6.05 | 3.87 | |
Net Debt/EBITDA |
(0.01) | 5.75 | 4.03 | 2.64 | |
Debt/Assets |
48.41% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
1.12 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.18 | 1.22 | 1.13 | 0.98 | |
Capex/Depreciation |
0.38 | 1.16 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
— | 0.00% | — | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(3.28) | (2.31) | (2.72) | (2.94) | |
Capex per Share |
0.01 | 0.03 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.27) | (2.28) | (2.72) | (2.94) | |
Cash per Share |
17.93 | 15.65 | 12.93 | 9.98 | |
Shareholders Equity per Share |
16.08 | 14.26 | 11.85 | 8.85 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.08 | 14.26 | 11.85 | 8.85 | |
Free Cash Flow |
(5.24) | (3.65) | (4.36) | (4.73) | |
Working Capital |
25.04 | 21.76 | 17.68 | 12.82 | |
Capital Expenditures |
0.02 | 0.05 | — | — | |
Net Current Asset Value |
(3.76) | (6.64) | (9.88) | (14.08) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
0.71 | 0.62 | 1.30 | 0.23 | |
Average Assets |
123.73 | 109.16 | 64.57 | 56.22 | |
Average Common Equity |
73.34 | 59.30 | 26.00 | 21.06 |
Columns are period end dates